Recro Pharma, Inc. (REPH) has seen some recent volatility in the marketplace and its common shares closed at $2.1300 yesterday. Traders are starting to take notice of REPH as the common shares traded as high as $2.2000 and as low as $2.0900 in the prior trading session.

Recro Pharma, Inc. (REPH) average trading volume is 354.60K. However, in the prior trading session Recro Pharma, Inc. (REPH) traded 226,898 shares. The First support level on REPH is $2.07 and the First resistance level on REPH is $8.83. REPH fifty day moving average is $3.1241 and REPH two hundred day moving average is $5.6539.

Recro Pharma, Inc. (REPH) most recent performance has been indicated by the recent movement in REPH common shares. REPH has performed -31.29% over the past month, REPH has performed -59.20% over the past 90 days and REPH has shown -80.18% over the past 1 year. Recro Pharma, Inc. (REPH) has a 1 year range of $2.0400 to $19.2100. Recro Pharma, Inc. (REPH) is trading 4.41% from its 1 year low and -88.91% from its 1 year high. Recro Pharma, Inc. (REPH) is displaying a 3.23% short float displaying the amount short in the float.

REPH has 23.58M shares outstanding and 23.26M shares in the float. Recro Pharma, Inc. (REPH) currently has a market cap of $50.82M and income of -4.30M. The EPS next quarter for REPH is -0.21 and forecasted EPS next year is 38.10%. The market cap of Recro Pharma, Inc. (REPH) at $50.82M represents how many Traders own shares of REPH and is calculated off the last price ($2.1300) of REPH and the amount of shares outstanding (23.58M) with Recro Pharma, Inc. (REPH).

Recro Pharma, Inc. (REPH) has aggregate cash (mrq) of 22.79M, aggregate cash per share (mrq) of 0.96, aggregate debt of REPH rests at 116.98M. Recro Pharma, Inc. (REPH) operating cash flow (ttm) is 5.52M, REPH leveraged free cash flow (ttm) is 8.97M.

REPH is trading -17.60% below (bearish) its SMA20, -38.86% below (bearish) its SMA50 and -76.72% below (bearish) its SMA200.